Drugs / Mometasone furoate nasal spray
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01920893 Background | Aug 2013 → Nov 2014 | nasal cavity polyp | Sanofi | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Mometasone furoate nasal spray | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01920893 ↗ |
| Route | Intranasal | “Nasal spray, 2 actuations in each nostril twice daily.” NCT01920893 ↗ |